321 related articles for article (PubMed ID: 20413364)
41. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
Nissen SE; Nicholls SJ; Wolski K; Howey DC; McErlean E; Wang MD; Gomez EV; Russo JM
JAMA; 2007 Mar; 297(12):1362-73. PubMed ID: 17384435
[TBL] [Abstract][Full Text] [Related]
42. Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review.
McKenney JM
Postgrad Med; 2012 Jan; 124(1):7-20. PubMed ID: 22314110
[TBL] [Abstract][Full Text] [Related]
43. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
[TBL] [Abstract][Full Text] [Related]
44. Dramatic regression of three-vessel disease under statin treatment in patients with stable angina pectoris.
Ercan S; Sari I; Davutoglu V
Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):259-60. PubMed ID: 23196941
[No Abstract] [Full Text] [Related]
45. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
Lo J; Lu MT; Ihenachor EJ; Wei J; Looby SE; Fitch KV; Oh J; Zimmerman CO; Hwang J; Abbara S; Plutzky J; Robbins G; Tawakol A; Hoffmann U; Grinspoon SK
Lancet HIV; 2015 Feb; 2(2):e52-63. PubMed ID: 26424461
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
Goldberg AC; Bittner V; Pepine CJ; Kelly MT; Thakker K; Setze CM; Lele A; Sleep DJ
Am J Cardiol; 2011 Mar; 107(6):898-905. PubMed ID: 21247520
[TBL] [Abstract][Full Text] [Related]
48. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
49. Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemia.
Ma L; Ballantyne CM; Belmont JW; Keinan A; Brautbar A
J Lipid Res; 2012 Nov; 53(11):2425-8. PubMed ID: 22896670
[TBL] [Abstract][Full Text] [Related]
50. Alternate-day versus daily atorvastatin in coronary artery disease: a randomized study.
Rifaie O; Zahran A; Nammas W
Anadolu Kardiyol Derg; 2012 Mar; 12(2):90-6. PubMed ID: 22281786
[TBL] [Abstract][Full Text] [Related]
51. Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.
Keating GM; Ormrod D
Drugs; 2002; 62(13):1909-44. PubMed ID: 12215067
[TBL] [Abstract][Full Text] [Related]
52. Lupus Atherosclerosis Prevention Study (LAPS).
Petri MA; Kiani AN; Post W; Christopher-Stine L; Magder LS
Ann Rheum Dis; 2011 May; 70(5):760-5. PubMed ID: 21177297
[TBL] [Abstract][Full Text] [Related]
53. A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.
Filippatos TD
Cardiovasc Drugs Ther; 2012 Jun; 26(3):245-55. PubMed ID: 22592524
[TBL] [Abstract][Full Text] [Related]
54. Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.
Mulders TA; Sivapalaratnam S; Stroes ES; Kastelein JJ; Guerci AD; Pinto-Sietsma SJ
JACC Cardiovasc Imaging; 2012 Mar; 5(3):252-60. PubMed ID: 22421169
[TBL] [Abstract][Full Text] [Related]
55. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.
Diepeveen SH; Verhoeven GW; Van Der Palen J; Dikkeschei LD; Van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
J Intern Med; 2005 May; 257(5):438-45. PubMed ID: 15836660
[TBL] [Abstract][Full Text] [Related]
56. Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
Burgstahler C; Reimann A; Beck T; Kuettner A; Heuschmid M; Kopp AF; Schroeder S
Int J Cardiovasc Imaging; 2006 Feb; 22(1):119-21. PubMed ID: 16374526
[No Abstract] [Full Text] [Related]
57. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
58. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
[TBL] [Abstract][Full Text] [Related]
59. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960
[TBL] [Abstract][Full Text] [Related]
60. Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.
Liamis G; Kakafika A; Bairaktari E; Miltiadous G; Tsimihodimos V; Goudevenos J; Achimastos A; Elisaf M
Curr Med Res Opin; 2002; 18(3):125-8. PubMed ID: 12094821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
